XACDURO (COPACKAGED)

Growth

sulbactam and durlobactam

NDAINTRAVENOUSPOWDERPriority Review
Approved
May 2023
Lifecycle
Growth
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Nov 17, 2035
118 months away
Patent Expiry
Nov 17, 2035
Exclusivity Expiry
May 23, 2033

Patent Records (4)

Patent #ExpiryTypeUse Code
9309245
Apr 2, 2033
Substance
—
9623014
Apr 2, 2033
U-2840
10376499
Nov 17, 2035
Product
U-2840
9968593
Nov 17, 2035
Product
U-2840
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers